JY
VOR icon

Jeff Yass’s Vor Biopharma VOR Stock Holding History

Jeff Yass’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Sell
64,600
-111,600
-63% -$1.69M ﹤0.01% 7757
2026
Q1 		$3.14M Sell
176,200
-179,700
-50% -$2.53M ﹤0.01% 5181
2025
Q4 		$4.66M Sell
355,900
-62,900
-15% -$1.17M ﹤0.01% 4139
2025
Q3 		$20.4M Buy
418,800
+415,825
+13,977% +$16.7M ﹤0.01% 2185
2025
Q2 		$96.4K Buy
+2,975
New +$26.3K ﹤0.01% 11820

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Jeff Yass's VOR Position: Q2 2026 in Review

Jeff Yass reduced its Vor Biopharma (VOR) stake by 93% in Q2 2026, selling an estimated $3.27M and leaving 16,454 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #11022.

Jeff Yass first reported a position in VOR in Q4 2021 and has held it in 14 quarters since. The position peaked at $4.15M in Q1 2026. 101 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Jeff Yass held 16,454 shares of Vor Biopharma worth $303K as of Q2 2026.
  • Jeff Yass sold 216,154 Vor Biopharma shares in Q2 2026, an estimated $3.27M.
  • Vor Biopharma made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11022 holding.
  • Jeff Yass first reported a position in Vor Biopharma in Q4 2021 and has held it in 14 quarters since.
  • Jeff Yass's Vor Biopharma position peaked at $4.15M in Q1 2026.
  • 101 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.